Other articles of interest

Clinical and genetic differences between heterozygous familial hypercholesterolemia patients with and without type 2 diabetes

Elisenda Climent, Sofía Pérez-Calahorra, David Benaiges, Xavier Pintó, Manuel Suárez-Tembra, Nuria Plana, Rosa M. Sánchez-Hernández, Pedro Valdivielso, Juan F. Ascaso, Juan Pedro-Botet,

Rev Esp Cardiol. 2020;73:718-24
Myocarditis related SARS-CoV-2 infection or vaccination: an expert consensus statement on its diagnosis and management

Manuel Barreiro-Pérez, Pablo Pastor Pueyo, Sergio Raposeiras-Roubín, Dolores Montero Corominas, Aitor Uribarri, Rocío Eiros Bachiller, José Rozado Castaño, Luisa García-Cuenllas Álvarez, Luis Serratosa Fernández, Fernando Domínguez, Domingo Pascual Figal,

Rev Esp Cardiol. 2023;76:555-63
Incidence of cardiovascular events and changes in the estimated risk and treatment of familial hypercholesterolemia: the SAFEHEART registry

Leopoldo Pérez de Isla, Raquel Arroyo-Olivares, Rodrigo Alonso, Ovidio Muñiz-Grijalvo, José Luis Díaz-Díaz, Daniel Zambón, Francisco Fuentes, Nelva Mata, Mar Piedecausa, M. Dolores Mañas, Juan F. Sánchez Muñoz-Torrero, José Pablo Miramontes-González, Raimundo de Andrés, Marta Mauri, Rocío Aguado, Ángel Brea, José M. Cepeda, José I. Vidal-Pardo, Ceferino Martínez-Faedo, Miguel Ángel Barba, Rosa Argüeso, Enrique Ruiz-Pérez, Alfredo Michán, Francisco Arrieta, María Riestra Fernández, Leire Pérez, José M. Pinilla, Gonzalo Díaz-Soto, Xavier Pintó, Teresa Padró, Lina Badimón, Pedro Mata,

Rev Esp Cardiol. 2020;73:828-34